CCN5 and gestational diabetes: Furthermore, there was a notable increase in the serum levels of CCN5 in the GDM group (379.41 ± 83.078 ng/mL) compared to the control group (212.02 ± 77.935 ng/mL, P < 0.0001) (Fig. 1a and Table 1).